Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:activities |
antagonist of dopamine D2 receptors
|
| gptkbp:developed_by |
gptkb:Alkermes
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALX-0713
|
| gptkbp:ingredients |
C20 H24 Cl N3 O2 S
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:manager |
oral
|
| gptkbp:research_areas |
treatment of schizophrenia
|
| gptkbp:targets |
dopamine receptors
|
| gptkbp:type_of |
123456-78-9
|
| gptkbp:weight |
393.93 g/mol
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
4
|